Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Witt

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viabilityR W Burt, O W Perkins, B E Oppenheim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1986
Clinical comparison of indium-111 acetylacetone and indium-111 tropolone granulocytesD S Schauwecker, R W Burt, H M Park, et al.
Human Gene Therapy|August 10, 1997
Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficienciesJ L Davis, R M Witt, P R Gross, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viabilityR W Burt, O W Perkins, B E Oppenheim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1986
Clinical comparison of indium-111 acetylacetone and indium-111 tropolone granulocytesD S Schauwecker, R W Burt, H M Park, et al.
Human Gene Therapy|August 10, 1997
Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficienciesJ L Davis, R M Witt, P R Gross, et al.
Pageof 2